Stocks Hitting 52-Week Highs

Sohu.com

shares rose 2.77% to touch a new 52-week high of $71.54. Analysts at Goldman Sachs upgraded the stock from “neutral” to “conviction buy.” Repros Therapeutics

shares reached a new 52-week high of $26.68 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®. Kythera Biopharmaceuticals

shares surged 24.40% to touch a new 52-week high of $41.71 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Ciena

shares gained 2.02% to create a new 52-week high of $25.82. Ciena shares have jumped 77.37% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.